cv-071D-0737-B391

publicações selecionadas

• artigo académico

  • Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers.  Pharmaceutics.  2023

• documento

  • Toxicity Comparison of Cubosomes Nanocarrier and its components: in vitro and in vivo tests 2024
  • Cubosomes as nanocarriers of anti-leishmania agents 2024
  • Design, optimization, and in vitro therapeutic performance of pH triggered doxorubicin from 2D and 3D lipid nanoassemblies 2023
  • Development and characterization of nanostructured lipid carriers containing quercetin and/or omega-3 2022